Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Home CompaniesIntegral Diagnostics Ltd

Integral Diagnostics Ltd

Healthcare Diagnostics & Research
PortfolioPortfolio WatchlistWatchlist
Company price
1.74 AUD 0.01 ( 0.58%)
Last update at 2026-11-06T05:10:00Z
VOLUME
687402
Market Cap
646.50M
P/E
28.83

Momentum Score

…

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, allied health professionals, and patients in Australia and New Zealand. It offers medical diagnostic imaging services, such as magnetic resonance imaging, computed tomography, mammography, ultrasound, and radiography, as well as nuclear medicine, including positron emission tomography. The company was founded in 1967 and is headquartered in East Melbourne, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
1.71
Low
1.75
High
52 Week Price Range
1.69
Low
2.60
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Integral Diagnostics (IDX) provides diagnostic imaging and radiology services through a network of clinics and hospital partnerships across Australia and New Zealand. It may benefit long term from demographic ageing, rising imaging utilisation, consolidation of clinic networks and technology upgrades that could support higher throughput and service mix. Investors may find the company attractive for its recurring referral-driven revenue, scale advantages in procurement and specialist staffing that appear positioned to support steady demand.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
1.73
Dividend Yield
5.45%
Revenue TTM
788.62M
Revenue Per Share
2.12
Gross Profit TTM
243.36M
Debt / Equity
0.88
ROE
3.21%
Net Debt
545.81M
ROCE
5.16%
Diluted EPS TTM
0.06

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax 32.11M 11.65M -57.08M 30.63M 22.56M
Minority interest -0.11M -0.15M - - -
Net income 21.93M 4.67M -60.70M 25.04M 14.60M
Selling general administrative 527.61M 418.16M 305.80M 285.58M 227.00M
Selling and marketing expenses - - 243.91M - -
Gross profit 168.55M 599.09M 446.78M 419.06M 339.52M
Reconciled depreciation 74.12M 56.53M 46.86M 43.49M 36.70M
Ebit 67.65M 31.16M -34.76M 49.00M 33.04M
Ebitda 141.99M 87.70M 12.10M 92.48M 69.74M
Depreciation and amortization 74.34M 56.53M 46.86M 43.49M 36.70M
Operating income 67.65M 57.53M 42.17M 39.83M 38.62M
Other operating expenses 720.97M 569.68M 359.96M 201.74M 149.74M
Interest expense 33.38M 28.77M 22.31M 18.36M 10.48M
Tax provision 10.07M 6.84M 3.56M 5.59M 7.96M
Interest income 1.26M 1.09M 0.86M 18.20M 0.04M
Net interest income -32.34M -27.81M -21.69M -17.94M -10.44M
Income tax expense 10.07M 6.84M 3.56M 5.59M 7.96M
Total revenue 788.62M 627.22M 469.70M 440.10M 358.74M
Total operating expenses 100.90M 541.55M 404.61M 379.92M 303.09M
Cost of revenue 620.07M 28.13M 22.92M 21.04M 19.22M
Total other income expense net -35.54M -45.88M -99.24M 9.44M -3.43M
Net income from continuing ops 22.04M 4.82M -60.70M 25.04M 14.60M
Net income applicable to common shares - 4.67M -60.70M 25.04M 14.60M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 1460.19M 1426.47M 744.28M 839.01M 783.01M
Intangible assets 50.57M 59.88M - 30.30M 28.02M
Other current assets 9.01M 4.08M 3.56M 2.47M 1.70M
Total liab 778.69M 732.53M 442.57M 465.96M 435.77M
Total stockholder equity 675.97M 693.00M 301.71M 373.05M 347.24M
Other current liab 108.88M 8.45M 59.34M 7.48M 16.38M
Common stock 736.28M - 335.00M 333.28M 322.54M
Capital stock 736.28M 735.40M - 333.28M 322.54M
Retained earnings -44.18M -37.13M -24.96M 49.56M 37.16M
Other liab - - - 34.89M 31.99M
Good will 796.19M 802.50M 373.34M 444.48M 352.46M
Other assets - - 0.00M 19.03M 17.25M
Cash 51.29M 52.10M 42.44M 33.85M 123.19M
Total current liabilities 148.63M 140.66M 87.15M 82.67M 80.00M
Current deferred revenue - - 1.46M 48.11M 37.72M
Net debt 545.81M 289.15M 315.36M 331.22M 217.80M
Short term debt 21.46M - 16.17M 16.67M 17.21M
Short long term debt - - - 2.45M 5.47M
Short long term debt total 597.10M - 357.80M 365.08M 340.99M
Other stockholder equity - - - -382.84M -359.70M
Property plant equipment - - - 282.46M 231.13M
Total current assets 99.38M 95.28M 74.82M 62.74M 153.98M
Long term investments 1.63M 0.01M - 0.01M 0.16M
Net tangible assets - - - -101.72M -33.24M
Short term investments - - - 0.38M 0.38M
Net receivables 35.66M 30.08M 27.18M 21.69M 19.41M
Long term debt 341.80M 341.25M - 221.14M 217.58M
Inventory 3.42M 2.52M 1.65M 1.85M 1.26M
Accounts payable 18.29M 20.59M 10.18M 10.41M 8.69M
Accumulated other comprehensive income -16.13M - -8.33M -9.79M -12.46M
Non currrent assets other - - 25.73M - -
Non current assets total 1360.81M 1331.19M 669.46M 776.27M 629.03M
Capital lease obligations 255.30M 243.75M - 141.48M 117.94M
Long term debt total - - - 348.41M 323.78M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments - -64.99M -27.90M -128.96M -55.69M
Change to liabilities - - - 1.40M -0.21M
Total cashflows from investing activities -46.44M -64.99M -27.90M -128.96M -55.69M
Net borrowings 0.00M 35.11M -2.42M -21.41M 13.04M
Total cash from financing activities -48.37M 0.71M -29.45M -31.85M 81.13M
Change to operating activities - - - 5.55M 0.70M
Net income 21.93M 4.67M -60.70M 25.04M 14.60M
Change in cash -0.82M 9.67M 8.58M -89.34M 60.99M
Begin period cash flow 52.10M 42.44M 33.85M 123.19M 62.20M
End period cash flow 51.29M 52.10M 42.44M 33.85M 123.19M
Total cash from operating activities 95.24M 73.77M 66.16M 71.42M 37.10M
Issuance of capital stock - - 1.72M 2.20M 91.83M
Depreciation 74.34M - 47.10M 43.49M 36.70M
Other cashflows from investing activities - 0.31M -4.03M -84.96M -27.92M
Dividends paid 25.93M -15.46M -13.82M -12.64M -20.86M
Change to inventory -4.00M -2.41M -0.47M - -
Change to account receivables -1.76M -0.03M -3.25M -0.35M -3.44M
Sale purchase of stock -1.71M -0.56M 1.72M 43.05M 114.15M
Other cashflows from financing activities -20.73M -18.94M -14.93M -19.25M -14.15M
Change to netincome - - - -9.45M -2.46M
Capital expenditures 49.64M 59.76M 23.88M 43.99M 27.77M
Change in working capital -8.73M 12.03M 3.98M -0.35M -3.44M
Stock based compensation - - 1.59M 2.54M -1.21M
Other non cash items 7.70M 61.75M 74.20M 2.89M -14.20M
Free cash flow 45.60M 14.01M 42.28M 27.42M 9.33M

Peer Comparison*

Sector: Healthcare Industry: Diagnostics & Research

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
IDX
Integral Diagnostics Ltd		 0.01
0.58%		 1.74 28.83 15.24 0.82 0.97 1.52 9.49
SHL
Sonic Healthcare Ltd		 0.18
0.91%		 20.06 16.16 17.21 0.90 1.15 1.36 8.10
ACL
Australian Clinical Labs Ltd		 0.04
1.25%		 3.24 26.67 16.84 0.81 3.95 1.24 5.12
HLS
Healius Ltd		 0.01
1.01%		 0.50 - 29.24 0.26 2.08 0.94 10.14
MVF
Monash Ivf Group Ltd		 -
-%		 0.74 37.00 16.21 1.07 1.17 1.79 11.73

Profile*

Integral Diagnostics Ltd

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, allied health professionals, and patients in Australia and New Zealand. It offers medical diagnostic imaging services, such as magnetic resonance imaging, computed tomography, mammography, ultrasound, and radiography, as well as nuclear medicine, including positron emission tomography. The company was founded in 1967 and is headquartered in East Melbourne, Australia.

288 Victoria Parade, East Melbourne, VIC, Australia, 3002

61 3 5339 0704

https://www.integraldiagnostics.com.au

3049

Name Title Year Born
Dr. Ian Kadish M.B.A., MBBCh, MBA CEO, MD & Director 1963
Mr. Craig White Chief Financial Officer NA
Mr. Paul McCrow Chief Operating Officer NA
Dr. Jacqueline Milne MBBS Exec. Director NA
Dr. Nazar Bokani M.D. Non-Independent Exec. Director NA
Mr. Julian Gully Chief Information Officer NA
Ms. Mica Duncalfe Chief People Officer NA
Dr. Lisa Sorger MBBS Chief Medical Officer NA
Ms. Kirsty Lally B.Com., C.A. Company Sec. NA
Dr. Ian Kadish M.B.A., MBBCh CEO, MD & Director 1963

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DAR
GBX 8.30
+23.42%
VTY
GBX 276.20
+8.23%
GTCO
GBX 0.09
+6.98%
GLV
GBX 2.34
+6.36%
BUR
GBX 249.20
+5.95%
TMI
GBX 0.72
-6.49%
HSBA
GBX 1291.40
-5.42%
RKT
GBX 5218.00
-4.85%
TGA
GBX 643.00
-4.03%
RKH
GBX 61.70
-3.89%

Equity Sectors*

  • Basic Materials

    -1.70%

  • Communication Services

    +0.33%

  • Consumer Cyclical

    +0.45%

  • Consumer Defensive

    -0.56%

  • Energy

    -0.25%

  • Financial Services

    +0.49%

  • Healthcare

    +0.20%

  • Industrials

    +0.74%

  • Real Estate

    +1.71%

  • Technology

    -2.81%

  • Utilities

    +0.28%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Cookies on this website

We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.

Essential cookies

These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.

Analytics cookies

We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.

Marketing cookies

These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.

Support

Hi! How can we help you today?

Loading…